Naksha Market intelligence
All research
AFRMAffirm HoldingsConsumer finance

Affirm at $71.50

The payment network is compounding. The credit cycle still gets the final vote.

Affirm is often described as a buy-now-pay-later company.

That description is too small.

Affirm is trying to become a payment network that connects merchants, consumers, banks, and long-term capital.

The opportunity is large because a better approval decision can help a merchant complete a sale without hiding the borrowing cost from the customer.

But this is still lending.

At $71.50, investors are paying for network growth, improving profitability, and credit performance that remains disciplined through a weaker economy.

What Affirm actually controls

Affirm controls the underwriting decision and the customer experience at checkout.

It does not need to fund every loan permanently. It can retain loans, sell them to third parties, or finance them through warehouses and securitizations.

That matters because the scarce asset is not capital alone. It is the ability to originate attractive loans, price risk quickly, and keep merchants and consumers returning.

In its fiscal 2026 Form 10-K, Affirm reported $50.2 billion of GMV, up 37%, and $4.26 billion of revenue, up 32%.

Active consumers reached 27.8 million, up 21%, while transactions per active consumer increased 20% to 7.0.

Why does that matter?

Both sides of the network are expanding: more customers are using Affirm, and existing customers are using it more often.

Business quality versus stock valuation

Affirm produced $417 million of GAAP operating income in fiscal 2026 after an $87 million loss the year before.

That is a real inflection.

It also generated $1.2 billion of operating cash flow, but that number needs care because loan purchases, sales, credit provisions, and funding flows are part of the operating model.

Stock-based compensation was $485 million, including amounts capitalized into software.

The company is profitable.

Owner earnings per share are not yet as clean as the headline suggests.

What $71.50 requires

I use fiscal 2032 as the checkpoint and a 10.5% required annual return over five years.

That hurdle starts with the 5.11% 10-year Treasury yield, adds the 4.14% implied U.S. equity risk premium, and uses a 1.30 bottom-up beta for a growth lender exposed to credit and capital markets.

At a 28 times terminal earnings multiple, today's price requires roughly $4.20 of normalized fiscal 2032 EPS.

That is achievable if GMV compounds, revenue less transaction costs expands, and funding partners continue to absorb loans on sensible terms.

It is not achievable if growth is purchased by relaxing underwriting.

Three possible outcomes

Conservative: about $33 today

Affirm earns $2.50 per share in fiscal 2032 and receives a 22 times terminal multiple.

GMV grows, but credit losses and funding costs absorb much of the operating leverage.

The network survives.

The stock disappoints.

Base case: about $68 today

Affirm earns $4.00 per share in fiscal 2032 and receives a 28 times terminal multiple.

Consumer engagement rises, merchant concentration falls, and GAAP profitability becomes durable after stock compensation and normal credit costs.

That outcome is close to the checked price.

Upside case: about $117 today

Affirm earns $6.00 per share in fiscal 2032 and receives a 32 times terminal multiple.

Affirm Card becomes a frequent-use product, the merchant network keeps broadening, and funding capacity scales without a deterioration in loan economics.

That is possible.

It is not what I would call conservative.

Credit, funding, and dilution risk

Affirm sold $21.9 billion of loans during fiscal 2026 and carried an average $8.2 billion of loans held for investment.

Average warehouse and securitization funding debt rose 27% to $7.5 billion.

That funding model can be efficient, but it makes capital-market access part of the product.

Amazon also represented 22% of fiscal 2026 GMV. Concentration is falling, but one relationship still matters enormously.

And stock compensation remains substantial.

Growth must outrun credit losses, funding costs, partner concentration, and dilution at the same time.

What to watch out for

  • GMV and transactions per active consumer - because frequency is the clearest evidence that Affirm is becoming a network rather than a checkout feature.
  • Revenue less transaction costs - because volume without unit economics is not value creation.
  • Delinquencies, charge-offs, and allowance coverage - because underwriting quality is easiest to overestimate near the top of a credit cycle.
  • Funding capacity and loan-sale gains - because capital partners must keep finding Affirm's paper attractive.
  • Amazon concentration - because diversification reduces bargaining and platform risk.
  • Diluted shares and stock compensation - because operating progress should belong to each share, not just to the company.

What could change the thesis

The thesis would strengthen if normalized earnings move above the $4.20 hurdle while credit metrics remain stable and merchant concentration keeps falling.

The thesis would weaken if GMV growth requires weaker underwriting, funding spreads widen, or reported profitability depends on loan-sale conditions that cannot persist.

The disconfirming evidence would be faster volume growth paired with worse risk-adjusted economics.

Bottom line

Affirm is building something more valuable than a financing button.

Business quality: improving rapidly.

Credit and funding risk: inseparable from the thesis.

Valuation: close to my base case.

At $71.50, the stock can work if network growth becomes durable owner earnings without sacrificing underwriting.

The practical principle: a lender does not prove its moat by making more loans. It proves it by earning more across the cycle without lowering the quality of the loans it makes.

Sources

Scenario values are analytical estimates, not company guidance or price targets. Educational only - not financial advice.

Continue the library

Compare the assumption, not just the ticker.

Browse all valuation research